Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

NAB (ASX:NAB) share price in focus on HY23 $4 billion profit

The National Australia Bank Ltd (ASX:NAB) share price is in the spotlight today after the big ASX bank share revealed its FY23 half-year result. 

The National Australia Bank Ltd (ASX: NAB) share price is in the spotlight today after the big ASX bank share revealed its FY23 half-year result.

These numbers that NAB has reported are for the six months to 31 March 2023.

NAB HY23 result

Here are some of the highlights from the result:

  • Revenue increased by 19.3%, but excluding the Citi acquisition it rose 16.6%
  • The net interest margin (NIM) increased 14 basis points (0.14%) to 1.77%
  • Total lending (gross loans and advances) increased 6.2%, while deposits went up 8.4%, excluding Citi the lending increased 4.2%
  • Expenses rose 11.6%, or 6.3% excluding Citi
  • There was a credit impairment charge of $393 million
  • Cash earnings grew by 17% year on year to $4.07 billion
  • Statutory net profit after tax (NPAT) grew 11.7% to $3.97 billion
  • Half-year dividend grew by 13.7% to $0.83 per share

The NIM is a measure showing how much lending profit a bank is making, it compares the loan rate to the funding cost (eg savings account interest). The higher NIM reflected higher earnings on deposits and capital as a result of the rising interest rate environment.

Revenue rose thanks to higher margins combined with stronger volumes and markets & treasury income.

Expenses rose because of salary increases, continued investment in technology and compliance, and payments for remediation. It was offset by productivity benefits.

There was a larger credit impairment charge because of lower house prices, volume growth, and a “modest increase” in specific charges from a low starting point.

NAB said that strong underlying profit growth reflected execution of its long-term strategy, which has allowed it to make “deliberate choices to target growth in higher returning segments combined with the impact of the interest rate environment.”

Arrears

Despite all of the interest rate rises, NAB revealed that the ratio of loans that are 90+ days past due reduced 9 basis points (0.09%) to 0.66%. It was 0.66% in the second half of FY22 as well. Will this start rising later this year? If arrears don’t rise, the NAB share price could benefit.

NAB explained that key drivers include improved delinquencies across the Australian home lending portfolio partially offset by an increase in business lending arrears.

The bank said that while there are encouraging signs that “inflation is moderating and interest rates are peaking in Australia, the full impact of a higher cost of living and higher interest rates on the outlook remains uncertain, particularly the extent to which households reduce discretionary spending and potential flow-on consequences to the broader economy.”

Dividend yield

I’m expecting NAB to grow its dividend in the second half of FY23, but if we add the latest $0.83 dividend to the $0.78 final dividend, that’s an annualised payout of $1.61, which is a fully franked dividend yield of 5.6%.

The dividend yield including the franking credits is around 8%. So, I think the actual FY23 dividend yield will be even higher.

Final thoughts on the NAB share price

I like that the business is taking a disciplined approach to home lending, rather than punishing its margins. Its loan growth is tracking at 0.6x system growth, it’s prioritising more attractive growth options across the bank, such as business lending. I think this is good for longer-term returns.

NAB noted that growth is slowing, but the Australian economy appears to be resilient. The dividend could be a key part of the returns if lending competition remains strong. I think NAB is one of the strongest banks, with a focus on sustainable profit generation. It’d be my pick of the big four.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content